Entering text into the input field will update the search result below

JPMorgan Chase initiates Inspire Medical at Overweight

  • Inspire Medical Systems (INSP +5.0%) was initiated with Overweight rating at JPMorgan Chase with price target of $148, an upside of 16.3% from current levels.
  • In the past 6 months, the stock has gained 165%; Wall Street Analysts rating is Bullish and it has exceeded the PT, $122.

  • Analyst Robbie Marcus believes that the company offers an effective, minimally invasive, and convenient solution for treating obstructive sleep apnea while addressing the shortcomings of existing treatment options.
  • He further adds that the company is well positioned to capture "meaningful share" in the $17B U.S. obstructive sleep apnea market opportunity.
  • Strong market opportunity exists for an alternative to CPAP that is effective and minimally invasive:

Recommended For You

About INSP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
INSP--
Inspire Medical Systems, Inc.